Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Post by felix10on Aug 09, 2016 10:42am
96 Views
Post# 25122464

Earnings

EarningsBRIEF-Aralez Q2 GAAP loss per share $0.27less than 1 minute ago by Thomson Reuters

Aug 9 (Reuters) - Aralez Pharmaceuticals Inc :

* Aralez reports second quarter 2016 financial results

* Q2 revenue $12.6 million versus $5.2 million

* Q2 GAAP loss per share $0.27

* Q2 earnings per share view $-0.22, revenue view $11.9 million -- 

Since the Tribute merger was completed in February, why don't earnings for the quarter ended June 30th include Tribute earnings?

<< Previous
Bullboard Posts
Next >>